淋巴细胞绝对计数及CA 125与非霍奇金淋巴瘤国际预后指数的关系  被引量:1

Relationship Between Absolute Lymphocyte Count and Serum CA125 and International Prognostic Index and the Prognostic Analysis of Patients with Non-Hodgkin Lymphoma

在线阅读下载全文

作  者:牛晓敏[1] 何慧清[1] 黎伟超[1] 李卫华[1] 许晓军[1] 

机构地区:[1]中山大学附属中山医院血液科,广东中山528403

出  处:《临床医学工程》2014年第7期860-862,共3页Clinical Medicine & Engineering

摘  要:目的本研究探计淋巴瘤患者外周淋巴细胞绝对计数(absolutelymphocytecount,ALC)及CAl25检测的临床意义及其与国际预后指数(intemationalprognosticindex,IPI)的关系。方法回顾性的分析127例非霍奇金淋巴瘤患者临床资料,对初诊时ALC、CAl25、IPI评分系统及疗效进行统计分析。结果中位随访23.1月(7.9—48.3月)总有效率(RR)为73.2%,完全缓解率(cR)为59.8%,总生存率(os)为55.1%。高ALC(aLc≥1.0×10VL)组和低ALC(aLc〈1.0×109/L)组R.R率为82.9%和61.4%(P=0.007),CR率为72.9%和43.9%(P=0.001),总生存率(os)为63.2%和30%(P=0.000)。高CA125组和CA125正常组RR率为40%和88.5%(P=0.000),CR率为20%和78.2%(P=0.000).总生存率为31%和75%(P=0.000)。将IpI评分0~1分和2分合并为低危组,3分、4~5分合并为高危组,统计分析显示,高危组淋巴细胞绝对计数较低危组明显降低(P=0.020),高危组CA125水平高于低危组(P=O,000)。结论ALC及CA125可与IPI评分系统一起用于评价弥漫大B细胞淋巴瘤患者的预后。Objective This study aims to investigate the clinical significance and prognostic value of peripheral blood absolute lymphocyte count(ALC) and serum CA125 at patients with non-Hodgkin lymphoma. Methods A totle of 127 patients with non-Hodgkin lymphoma in our department of hematotogy fxom 2008-01 to 2013-01 were enrolled arid analyzed retrospectively. The correlation between different ALC level and serum CA125 and international prognostic index were statistically analyzed. Results At a median follow-up of 23.1 months, the overall response rate (RR)was 73.2% with 59.8% complete remission rate (CR) and 55.1% overall survival rate (OS). Patients with high ALC ( ≥ 1.0 x 109/L) at diagnosis tended to have higher RR, CR and OS. Patients with low ALC ( 〈 1.0 x 109/L) at diagnosis had bad treatment effect. ALC level in IPI 3 - 5 groups decreased significantly as compared with those in IPI 0 - 2 groups (P = 0.020). Serum levels of CA125 were significantly elevated in the group IPI score ≥2 (P = 0.000). Conclusions Our data show that ALC and serum CA125 at diagnosis with IPI scores system can be used for evaluating the prognosis of non-Hodgkin lymphoma patients

关 键 词:淋巴细胞绝对数 CA125 淋巴瘤 国际预后指数 预后 

分 类 号:R733[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象